检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:伏钢[1] 冯军[1] 高远 王新润 FU Gang;FENG Jun;GAO Yuan;WANG Xinrun(Department of Ultrasound,Wuxi Second People's Hospital Affiliated to Nanjing Medical University,Wuxi,Jiangsu Province,214000 China)
机构地区:[1]南京医科大学附属无锡市第二人民医院超声科,江苏无锡214000
出 处:《系统医学》2022年第6期63-65,81,共4页Systems Medicine
摘 要:目的探讨DSA联合超声引导下单腔中心静脉导管置入术式在肾囊肿硬化治疗中的应用价值。方法选取2019年1月—2020年8月该院收治的72例肾囊肿硬化患者为研究对象,按照治疗方式的不同,分为对照组和观察组,每组36例。其中,对照组在超声引导下行单腔中心静脉导管置入术治疗,观察组在对照组治疗的基础上联合数字减影血管造影(DSA)治疗,比较两组治疗有效率及并发症情况。结果观察组治疗总有效率为94.44%,明显优于对照组,差异有统计学意义(χ^(2)=4.181,P<0.05)。观察组不良反应发生率低于对照组,差异有统计学意义(χ^(2)=4.600,P<0.05)。结论超声引导下联合DSA行单腔中心静脉导管置入术治疗肾囊肿硬化,可以提高临床治疗效果,降低不良反应发生情况,值得临床推广。Objective To investigate the application value of DSA combined with ultrasound-guided single-lumen central venous catheter placement in renal cyst sclerotherapy.Methods A total of 72 patients with renal cyst sclerosis who were treated in the hospital from January 2019 to August 2020 were selected as the research objects.According to different treatment methods,they were divided into control group and observation group,36 cases in each group.Among them,the control group was treated with ultrasound-guided single-lumen central venous catheter placement,and the observation group was treated with digital subtraction angiography(DSA)based on the treatment of the control group.The treatment efficacy and complications were compared between the two groups.Results The total effective rate of the observation group was 94.44%,which was significantly better than that of the control group,and the difference was statistically significant(χ^(2)=4.181,P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(χ^(2)=4.600,P<0.05).Conclusion Ultrasound-guided single-lumen central venous catheter placement combined with DSA in the treatment of renal cyst sclerosis can improve the clinical treatment effect and reduce the occurrence of adverse reactions.It is worthy of clinical promotion.
分 类 号:R445.1[医药卫生—影像医学与核医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7